Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

Chinese Pulmonary Vascular Disease Research Group

Status: Enrolling

Conditions: Takayasu Arteritis With Pulmonary Artery Involvement; PAH Targeted Medication; Percutaneous Transluminal Pulmonary Angioplasty

Treatments: Device: Percutaneous transluminal pulmonary angioplasty

Study type: Observational

Funder types: Other

Identifiers

NCT05388682

TAPAI

Details and patient eligibility

About

1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement
2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement

Full description

At baseline, FAPI and FDG are performed to evaluate the activity of takayasu arteritis with pulmonary artery involvement. FAPI is also used to predict the treatment efficacy and prognosis of takayasu arteritis with pulmonary artery involvement.

Enrollment: 200 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients diagnosed with Takayasu arteries with pulmonary arteries involvement

Exclusion criteria

• Patients had pulmonary artery stenosis arising from CTEPH, fibrosing mediastinitis and congenital pulmonary artery stenosis